Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | VRTX | BMY | AMGN | GILD | MRNA |
Company | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 419.48 | 53.39 | 287.86 | 73.25 | 111.10 |
High | 420.67 | 54.20 | 288.57 | 73.78 | 112.00 |
Low | 415.06 | 53.39 | 285.15 | 73.24 | 106.56 |
Last | 418.81 | 54.16 | 285.60 | 73.49 | 106.99 |
Change | +1.49 | +0.91 | -0.70 | +0.48 | -3.60 |
% Change | +0.36% | +1.71% | -0.24% | +0.66% | -3.26% |
Volume | 330,030 | 3,838,361 | 605,881 | 2,200,643 | 1,867,501 |
20-Day Average Volume | 968,222 | 20,210,709 | 2,869,592 | 7,149,980 | 3,957,023 |
Previous Close | 417.32 | 53.25 | 286.30 | 73.01 | 110.59 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 415.28 | 52.56 | 276.55 | 73.55 | 104.03 |
20-Day Raw Stochastic | 44.41% | 77.33% | 85.00% | 34.82% | 66.44% |
20-Day Relative Strength | 51.51% | 62.61% | 52.94% | 45.76% | 55.39% |
Weighted Alpha | +31.52 | -18.41 | +18.07 | -11.75 | -20.45 |
Today's Opinion | 56% Buy | 24% Buy | 40% Buy | 88% Sell | 72% Buy |
Previous Opinion | 56% Buy | 8% Buy | 40% Buy | 88% Sell | 72% Buy |
Last Month's Opinion | 100% Buy | 56% Sell | 24% Buy | 40% Sell | 8% Sell |
Performance | |||||
5-Days | |||||
%Chg | +0.78% since 03/21/24 | +4.66% since 03/21/24 | +3.09% since 03/21/24 | +0.48% since 03/21/24 | +2.62% since 03/21/24 |
Low | 412.19 on 03/22/24 | 51.52 on 03/22/24 | 275.10 on 03/22/24 | 72.11 on 03/26/24 | 103.51 on 03/22/24 |
High | 420.67 on 03/28/24 | 54.20 on 03/28/24 | 288.57 on 03/28/24 | 73.78 on 03/28/24 | 111.80 on 03/26/24 |
1-Month | |||||
%Chg | -1.87% since 02/28/24 | +6.04% since 02/28/24 | +2.90% since 02/28/24 | +1.02% since 02/28/24 | +9.58% since 02/28/24 |
Low | 406.97 on 03/15/24 | 50.28 on 02/29/24 | 268.17 on 03/15/24 | 71.92 on 02/29/24 | 92.11 on 03/01/24 |
High | 433.99 on 03/04/24 | 55.03 on 03/13/24 | 288.57 on 03/28/24 | 76.21 on 03/11/24 | 114.25 on 03/11/24 |
3-Month | |||||
%Chg | +2.37% since 12/28/23 | +5.41% since 12/28/23 | -1.02% since 12/28/23 | -9.49% since 12/28/23 | +8.13% since 12/28/23 |
Low | 403.43 on 01/02/24 | 47.58 on 02/06/24 | 268.17 on 03/15/24 | 71.37 on 02/16/24 | 84.06 on 02/13/24 |
High | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
6-Month | |||||
%Chg | +18.86% since 09/28/23 | -7.13% since 09/28/23 | +5.42% since 09/28/23 | -2.63% since 09/28/23 | +6.53% since 09/28/23 |
Low | 341.85 on 10/03/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 71.37 on 02/16/24 | 62.55 on 11/02/23 |
High | 448.40 on 01/30/24 | 58.46 on 09/29/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 107,797,104 | 107,924,920 | 153,433,600 | 90,903,080 | 42,342,700 |
Shares Outstanding, K | 258,308 | 2,026,759 | 535,919 | 1,245,077 | 382,880 |
Annual Sales | 9,869,200,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
Annual Net Income | 3,619,600,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
Last Quarter Sales | 2,517,700,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
Last Quarter Net Income | 968,800,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
60-Month Beta | 0.35 | 0.38 | 0.58 | 0.18 | 1.60 |
Per-Share Information | |||||
Most Recent Earnings | 4.20 on 02/05/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
Latest Earnings Date | 05/06/24 | 04/25/24 | 04/25/24 | 04/25/24 | 05/02/24 |
Most Recent Dividend | N/A | 0.600 on 01/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 31.14 | 7.01 | 15.11 | 10.78 | 0.00 |